Literature DB >> 19887771

Long-term survival after hospitalization for community-acquired and healthcare-associated pneumonia.

Laura M Cecere1, Gordon D Rubenfeld, David R Park, Richard K Root, Christopher H Goss.   

Abstract

BACKGROUND: Elderly patients surviving community-acquired pneumonia (CAP) have subsequent increased mortality. However, little is known regarding long-term survival in younger adults or those with healthcare-associated pneumonia (HCAP).
OBJECTIVES: To identify factors associated with mortality and compare long-term survival in patients hospitalized with HCAP to that of patients with CAP.
METHODS: We determined survival after discharge as of December 2002 in a patient cohort admitted with pneumonia between June 1994 and May 1996. We used the Cox proportional hazard model to estimate differences in survival after controlling for confounders.
RESULTS: Of the 522 patients hospitalized with pneumonia, 457 survived to discharge. One hundred sixty-four patients (36%, 95% confidence interval, CI, 31-40%) were admitted with HCAP, while 293 (64%, 95% CI 60-69%) were admitted with CAP. Of the 181 deaths in the follow-up period, 70 occurred in patients under age 65 years admitted with HCAP (53% death rate, 95% CI 44-62%). Nineteen of these deaths (27%, 95% CI 17-39%) occurred in the absence of HIV infection. In patients under the age of 65 whose only risk factor for HCAP was treatment for pneumonia or hospitalization in the previous 90 days, 4 of 13 patients (31%, 95% CI 9-61%) died. Twenty percent (95% CI 15-26%) of patients under age 65 years admitted with CAP died during the follow-up.
CONCLUSIONS: Admission for HCAP, and to a lesser degree CAP, is associated with increased long-term mortality even in young patients. Future studies are warranted to identify interventions to improve survival in this population. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19887771      PMCID: PMC2835377          DOI: 10.1159/000255764

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  20 in total

1.  Medium-term survival after hospitalization with community-acquired pneumonia.

Authors:  Grant W Waterer; Lori A Kessler; Richard G Wunderink
Journal:  Am J Respir Crit Care Med       Date:  2003-12-23       Impact factor: 21.405

2.  New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases.

Authors:  G D Fang; M Fine; J Orloff; D Arisumi; V L Yu; W Kapoor; J T Grayston; S P Wang; R Kohler; R R Muder
Journal:  Medicine (Baltimore)       Date:  1990-09       Impact factor: 1.889

3.  The etiology of community-acquired pneumonia at an urban public hospital: influence of human immunodeficiency virus infection and initial severity of illness.

Authors:  D R Park; V L Sherbin; M S Goodman; A D Pacifico; G D Rubenfeld; N L Polissar; R K Root
Journal:  J Infect Dis       Date:  2001-06-26       Impact factor: 5.226

4.  The impact of confounder selection criteria on effect estimation.

Authors:  R M Mickey; S Greenland
Journal:  Am J Epidemiol       Date:  1989-01       Impact factor: 4.897

5.  Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia.

Authors:  Eric M Mortensen; Wishwa N Kapoor; Chung-Chou H Chang; Michael J Fine
Journal:  Clin Infect Dis       Date:  2003-11-20       Impact factor: 9.079

6.  Pneumonia: still the old man's friend?

Authors:  Vladimir Kaplan; Gilles Clermont; Martin F Griffin; Jan Kasal; R Scott Watson; Walter T Linde-Zwirble; Derek C Angus
Journal:  Arch Intern Med       Date:  2003-02-10

7.  Cost and incidence of social comorbidities in low-risk patients with community-acquired pneumonia admitted to a public hospital.

Authors:  Christopher H Goss; Gordon D Rubenfeld; David R Park; Vandy L Sherbin; Michelle S Goodman; Richard K Root
Journal:  Chest       Date:  2003-12       Impact factor: 9.410

8.  Deaths: leading causes for 2004.

Authors:  Melonie Heron
Journal:  Natl Vital Stat Rep       Date:  2007-11-20

9.  Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes--proceedings of the HCAP Summit.

Authors:  Marin H Kollef; Lee E Morrow; Robert P Baughman; Donald E Craven; John E McGowan; Scott T Micek; Michael S Niederman; David Ost; David L Paterson; John Segreti
Journal:  Clin Infect Dis       Date:  2008-04-15       Impact factor: 9.079

10.  2005 National Hospital Discharge Survey.

Authors:  Carol J DeFrances; Margaret J Hall
Journal:  Adv Data       Date:  2007-07-12
View more
  13 in total

Review 1.  Elderly patients with community-acquired pneumonia: optimal treatment strategies.

Authors:  Ulrich Thiem; Hans-Jürgen Heppner; Ludger Pientka
Journal:  Drugs Aging       Date:  2011-07-01       Impact factor: 3.923

2.  Clinical impact of broad-spectrum empirical antibiotic therapy in patients with healthcare-associated pneumonia: a multicenter interventional study.

Authors:  Marco Falcone; Salvatore Corrao; Giuseppe Licata; Pietro Serra; Mario Venditti
Journal:  Intern Emerg Med       Date:  2012-06-12       Impact factor: 3.397

3.  Fluoroquinolones in community-acquired pneumonia: guide to selection and appropriate use.

Authors:  Christopher R Frei; Matthew J Labreche; Russell T Attridge
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546

Review 4.  Long-term prognosis in community-acquired pneumonia.

Authors:  Marcos I Restrepo; Paola Faverio; Antonio Anzueto
Journal:  Curr Opin Infect Dis       Date:  2013-04       Impact factor: 4.915

Review 5.  Guideline-concordant antimicrobial therapy for healthcare-associated pneumonia: a systematic review and meta-analysis.

Authors:  Anthony X Troitino; Jahan Porhomayon; Ali A El-Solh
Journal:  Lung       Date:  2013-04-10       Impact factor: 2.584

6.  Multiple logistic regression analysis of risk factors in elderly pneumonia patients: QTc interval prolongation as a prognostic factor.

Authors:  Yasuyuki Taooka; Gen Takezawa; Miki Ohe; Akihisa Sutani; Takeshi Isobe
Journal:  Multidiscip Respir Med       Date:  2014-11-22

7.  Pneumonia severity, comorbidity and 1-year mortality in predominantly older adults with community-acquired pneumonia: a cohort study.

Authors:  Thomas Wesemann; Harald Nüllmann; Marc Andre Pflug; Hans Jürgen Heppner; Ludger Pientka; Ulrich Thiem
Journal:  BMC Infect Dis       Date:  2015-01-08       Impact factor: 3.090

8.  Long-term survival and healthcare utilization outcomes attributable to sepsis and pneumonia.

Authors:  Andrew Dick; Hangsheng Liu; Jack Zwanziger; Eli Perencevich; E Yoko Furuya; Elaine Larson; Monika Pogorzelska-Maziarz; Patricia W Stone
Journal:  BMC Health Serv Res       Date:  2012-11-26       Impact factor: 2.655

Review 9.  Evidence for a causal link between sepsis and long-term mortality: a systematic review of epidemiologic studies.

Authors:  Manu Shankar-Hari; Michael Ambler; Viyaasan Mahalingasivam; Andrew Jones; Kathryn Rowan; Gordon D Rubenfeld
Journal:  Crit Care       Date:  2016-04-13       Impact factor: 9.097

10.  Cost effectiveness of adherence to IDSA/ATS guidelines in elderly patients hospitalized for Community-Aquired Pneumonia.

Authors:  Michael E Egger; John A Myers; Forest W Arnold; Leigh Ann Pass; Julio A Ramirez; Guy N Brock
Journal:  BMC Med Inform Decis Mak       Date:  2016-03-15       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.